Tham khảo Zaleplon

  1. ↑ Elie R, Rüther E, Farr I, Emilien G, Salinas E (tháng 8 năm 1999). “Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group”. The Journal of Clinical Psychiatry 60 (8): 536–44. PMID 10485636. doi:10.4088/JCP.v60n0806. 
  2. ↑ “Pace Pharmacy – About Our Store”. 
  3. ↑ Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN (tháng 12 năm 2012). “Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration”. BMJ 345: e8343. PMC 3544552. PMID 23248080. doi:10.1136/bmj.e8343. 
  4. ↑ Verster JC, Veldhuijzen DS, Volkerts ER (tháng 8 năm 2004). “Residual effects of sleep medication on driving ability”. Sleep Medicine Reviews 8 (4): 309–25. PMID 15233958. doi:10.1016/j.smrv.2004.02.001. 
  5. ↑ Barbera J, Shapiro C (2005). “Benefit-risk assessment of zaleplon in the treatment of insomnia”. Drug Safety 28 (4): 301–18. PMID 15783240. doi:10.2165/00002018-200528040-00003. 
  6. ↑ Wang JS, DeVane CL (2003). “Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacology Bulletin 37 (1): 10–29. PMID 14561946. doi:10.1007/BF01990373. 
  7. ↑ “Zaleplon”. pubchem.ncbi.nlm.nih.gov (bằng tiếng Anh). U.S. National Library of Medicine. Truy cập ngày 10 tháng 6 năm 2018. 
  8. ↑ J. P. Dusza et al., Bằng sáng chế Hoa Kỳ số 4.626.538 (1986 to Am. Cyanamid).
  9. ↑ “Anil M. Naik et al /Int.J. ChemTech Res.2010,2(1)” (PDF). 
  10. ↑ “Synthesis of Zaleplon”. 
  11. ↑ Banasik M, Komura H, Shimoyama M, Ueda K (tháng 1 năm 1992). “Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase”. The Journal of Biological Chemistry 267 (3): 1569–75. PMID 1530940. 
  12. ↑ Dehmel F, Weinbrenner S, Julius H, Ciossek T, Maier T, Stengel T, Fettis K, Burkhardt C, Wieland H, Beckers T (tháng 7 năm 2008). “Trithiocarbonates as a novel class of HDAC inhibitors: SAR studies, isoenzyme selectivity, and pharmacological profiles”. Journal of Medicinal Chemistry 51 (13): 3985–4001. PMID 18558669. doi:10.1021/jm800093c. 
  13. ↑ Salomon, Robert G.; Raychaudhuri, Swadesh R. (1984). “Convenient preparation of N,N-dimethylacetamide dimethyl acetal”. The Journal of Organic Chemistry 49 (19): 3659. doi:10.1021/jo00193a045. 

Tài liệu tham khảo

WikiPedia: Zaleplon http://en.cnki.com.cn/Article_en/CJFDTotal-ZYSG200... http://www.chemspider.com/Chemical-Structure.5517.... http://www.drugs.com/monograph/zaleplon.html http://linkinghub.elsevier.com/retrieve/pii/S10870... http://www.google.com/patents?vid=4626538 http://www.medworksmedia.com/psychopharmbulletin/p... http://www.pacepharmacy.com/retailer/store_templat... http://sphinxsai.com/sphinxsaiVol_2No.1/ChemTech_V... //www.ncbi.nlm.nih.gov/pmc/articles/PMC3544552 //www.ncbi.nlm.nih.gov/pubmed/10485636